Mutations In Stat3 And Diagnostic Guidelines For Hyper-Ige Syndrome
View/ Open
Date
2010Author
Woellner, Cristina
Gertz, E. Michael
Schaeffer, Alejandro A.
Lagos, Macarena
Perro, Mario
Glocker, Erik-Oliver
Pietrogrande, Maria C.
Cossu, Fausto
Franco, Josee L.
Matamoros, Nuria
Pietrucha, Barbara
Heropolitanska-Pliszka, Edyta
Yeganeh, Mehdi
Moin, Mostafa
Espanol, Teresa
Ehl, Stephan
Gennery, Andrew R.
Abinun, Mario
Breborowicz, Anna
Niehues, Tim
Kilic, Sara Sebnem
Junker, Anne
Turvey, Stuart E.
Plebani, Alessandro
Sanchez, Berta
Garty, Ben-Zion
Pignata, Claudio
Cancrini, Caterina
Litzman, Jiri
Sanal, Oezden
Baumann, Ulrich
Bacchetta, Rosa
Hsu, Amy P.
Davis, Joie N.
Hammarstroem, Lennart
Davies, E. Graham
Eren, Efrem
Arkwright, Peter D.
Moilanen, Jukka S.
Viemann, Dorothee
Khan, Sujoy
Laszlo Marodi
Cant, Andrew J.
Freeman, Alexandra F.
Puck, Jennifer M.
Holland, Steven M.
Grimbacher, Bodo
xmlui.mirage2.itemSummaryView.MetaData
Show full item recordAbstract
Background: The hyper-IgE syndrome (HIES) is a primary immunodeficiency characterized by infections of the lung and skin, elevated serum IgE, and involvement of the soft and bony tissues. Recently, HIES has been associated with heterozygous dominant-negative mutations in the signal transducer and activator of transcription 3 (STAT-3) and severe reductions of T(H)17 cells. Objective: To determine whether there is a correlation between the genotype and the phenotype of patients with HIES and to establish diagnostic criteria to distinguish between STAT3 mutated and STAT3 wild-type patients. Methods: We collected clinical data, determined T(H)17 cell numbers, and sequenced STAT3 in 100 patients with a strong clinical suspicion of HIES and serum IgE > 1000 IU/mL. We explored diagnostic criteria by using a machine-learning approach to identify which features best predict a STAT3 mutation. Results: In 64 patients, we identified 31 different STAT3 mutations, 18 of which were novel. These included mutations at splice sites and outside the previously implicated DNA-binding and Src homology 2 domains. A combination of 5 clinical features predicted STAT3 mutations with 85% accuracy. T(H)17 cells were profoundly reduced in patients harboring STAT-3 mutations, whereas 10 of 13 patients without mutations had low (<1%) T(H)17 cells but were distinct by markedly reduced IFN-gamma-producing CD4(+)T cells. Conclusion: We propose the folio-wing diagnostic guidelines for STAT3-deficient HIES. Possible: IgE >1000IU/mL plus a weighted score of clinical features >30 based on recurrent pneumonia, newborn rash, pathologic bone fractures, characteristic face, and high palate. Probable: These characteristics plus lack of T(H)17 cells or a family history for definitive HIES. Definitive: These characteristics plus a dominant-negative heterozygous mutation in STAT3. (J Allergy Clin Immunol 2010;125:424-32.)